Sunday, March 15

Clothing&Leisure

Kexing Biopharm's innovative drug "GB19 Injection" received approval from NMPA to conduct clinical trials in China

Recently, Kexing Biopharm's innovative drug "GB19 Injection" for the treatment of systemic lupus erythematosus (SLE) received approval from National Medical Products Administration (NMPA) to conduct clinica...

Chemicals & Minerals

Kexing Biopharm's innovative drug "GB19 Injection" received approval from NMPA to conduct clinical trials in China

Recently, Kexing Biopharm's innovative drug "GB19 Injection" for the treatment of systemic lupus erythematosus (SLE) received approval from National Medical Products Administration (NMPA) to conduct clinical trials in China. Differ...

Transportation

Kexing Biopharm's innovative drug "GB19 Injection" received approval from NMPA to conduct clinical trials in China

Recently, Kexing Biopharm's innovative drug "GB19 Injection" for the treatment of systemic lupus erythematosus (SLE) received approval from National Medical Products Administration (NMPA) to conduct clinica...